NASDAQ
80.84USD
-2.00 (-2.41%)
We have scored 80 news catalysts on Disc Medicine, Inc. (IRON) over the past 12 months. The biggest single-day move next to one of them came Jun 27, 2026, when IRON closed +6.6%: “ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages UP Fintech Holding Limited Investors to Inquire About Securities Class Action Investigation - TIGR”. Coverage across the window leans negative (average ticker sentiment −0.74). Most of the impact sits in price momentum and institutional appeal.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
3.1B
P/E
—
EPS
—
Beta
2.11
52W range
40-99.5
Day range
78.61–82.86
Open
82.32
Prev close
82.84
Volume
685K
Avg volume
758.9K
Dividend
0.00
IPO
2020-08-12
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Disc Medicine, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for IRON: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
